Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Glecaprevir-pibrentasvir

Brand: Maviret®
NICE TA: 499
Indication: Chronic hepatitis C in adults (NICE TA499)
Disease category: Infection
Commissioning responsibility: NHS England
PbR excluded: Yes

Background

Glecaprevir–pibrentasvir is recommended, within its marketing authorisation, as an option for treating chronic hepatitis C in adults, only if the company provides the drug at the same price or lower than that agreed with the Commercial Medicines Unit.

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

NICE TA499 - Glecaprevir–pibrentasvir for treating chronic hepatitis C

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red